Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
21
Number of overlapping holdings
9.5%
% of IBBQ's 220 holdings also in PBE
75.0%
% of PBE's 28 holdings also in IBBQ
Overlap by Weight
Sector Drift (IBBQ minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBBQ |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 8.1% | 5.1% | 5.1% |
|
AMGEN INC | 8.2% | 5.0% | 5.0% |
|
REGENERON PHARMACEUTICALS | 7.1% | 4.5% | 4.5% |
|
BIOGEN IDEC INC | 2.1% | 5.0% | 2.1% |
|
UNITED THERAPEUTICS CORP | 1.4% | 4.4% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
IBBQ Overweight Relative to PBE
|
VERTEX PHARMACEUTICALS INC | 8.5% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.4% |
|
ALNYLAM PHARMACEUTICALS INC | 3.6% |
|
AMGEN INC | 3.3% |
|
GILEAD SCIENCES INC | 2.9% |
|
REGENERON PHARMACEUTICALS | 2.5% |
 |
ARGENX SE ADR | 1.9% |
 |
SANOFI-AVENTIS-ADR | 1.7% |
|
SUMMIT THERAPEUTICS INC | 1.5% |
|
INSMED INC | 1.5% |
IBBQ Underweight Relative to PBE
|
NATERA INC | -4.7% |
|
NEUROCRINE BIOSCIENCES INC | -3.8% |
|
TG THERAPEUTICS INC | -3.8% |
|
PROTAGONIST THERAPEUTICS, INC. | -3.6% |
|
CATALYST PHARMACEUTICAL PART | -3.3% |
|
UNITED THERAPEUTICS CORP | -3.0% |
|
ILLUMINA INC | -3.0% |
|
BIOGEN IDEC INC | -2.9% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.8% |
|
DYNAVAX TECHNOLOGIES CORP | -2.7% |